In 1979, intravenous infusions of a GIP antiserum in rats were able to inhibit the action of GIP on glucose-induced insulin release, hereby, showing the first inhibition of GIP activity (58) ( Figure 3 )
At Cymbiotika, we believe that true wellness is built from the inside out, focusing on how our cells function and how well our bodies can absorb the nutrients we provide them
Released By Bachem News Releases Visit Bachem at the Oligo Chemistry & Therapeutics Online Symposium 2024 Fri, 27 Sept, 2024 Released By Bachem News Releases Visit Bachem at the Nordic Life Science Days 2024 Tue, 17 Sept, 2024 - Thu, 19, Sept 2024 Released By Bachem News Releases Visit Bachem at the Boulder Peptide Symposium 2024 Mon, 16 Sept, 2024 - Thu, 19 Sept 2024 Released By Bachem Sponsored Content How to assess and reduce Nitrosamine Contamination Risks in Peptide APIs Recent years have seen drug recalls based on nitrosamine drug substance related impurities (NDSRIs), with medical agencies advising API manufacturers to implement risk assessment and mitigation strategies to meet safety and regulatory requirements
If your order is delayed, contact customer support for assistance